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Abstract 
This study aims to determine whether -308 G/A polymorphism in tumor necrosis factor-alpha gene (TNF-α), is 
associated with susceptibility to rheumatoid arthritis in Iraqi population of TNF-a. This case-controlled study 
was performed including 42 RA patients (15 males, 27 females; mean age 55,67years; range 30 to 72 years) and 
30 healthy controls (10 males, 20 females; mean age 52,8 years; range 30 to 70 years). We determined the 
frequency of -308 G/A TNF-a gene polymorphism by amplification refractory mutation system-polymerase 
chain reaction restriction fragment length polymorphism (ARMS-PCR). Also, we determined the association of 
TNF-α -308 G/A polymorphism with rheumatoid arthritis in Iraqi patients. There wassignificant difference 
between genotype frequency of -308 G/A polymorphism and rheumatoid arthritis. In RA patients, the genotype 
frequency of -308 G/Apolymorphism was GG (11.90%), GA (45.24%), and AA (42.86%). In the control group, 
the genotype frequency of -308 G/A polymorphism was GG (3.33%),GA (83.33%), and AA (13.33%). 
Statistical analysis showed significant association in the genotype frequency of this AA polymorphism in RA 
patients (p<0.009*), and GG genotype bot no significant (p=0.390). There was significant difference in 
genotype frequency of this GA polymorphism in control (p<0.001*). Our findings demonstrate that the TNF-α-
308 G/A gene polymorphism may represent a significant risk factor for rheumatoid arthritis in Iraqi population 
and there is association between the TNF-α-308 G/A polymorphism and rheumatoid arthritis patients. 
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1. Introduction 
Rheumatoid arthritis (RA) is a autoimmune disease characterized by chronic inflammation of the joints tissue 
[1]. which may lead to structural damage of the bone and cartilage, that is associated with extra-articular, 
articular and systemic effects; including kidney, spleen, lungs, eyes and heart [2]. It is estimated that the disease 
affects 0.5 to 2% of the world’s population [3].This disorder is three times more frequent in females than males. 
The Prevalence of disease increases with age and is highest in females older than 65 years [4]. 
The tumor necrosis factor alpha (TNF-α) have roles in the pathobiology of rheumatoid arthritis. It is a major 
pro-inflammatory and anti-inflammatory cytokines; exert their influence, depending on the time, cellular 
location and extent of release. TNF-α is a axial cytokine in rheumatoid arthritis, lead to enhancement of 
apoptosis and regulation of cell proliferation [5]. TNF-a is produced mostly by activating macrophages although 
it can be produced by T CD4+ cells and natural killer cells [6]. 
The TNF gene is located on chromosome 6 (chromosome 6p21.3) within the major histocompatibility complex 
(MHC).The expression high of TNF-α responsible for ROS (reactive oxygen species) released in Rheumatoid 
arthritis, this lead to damage of patient tissues, in addition to inflammation [7].There are different genetic 
variations in TNF-α gene such as ARMS (Amplification refractory mutation system) and SNPs (single 
nucleotide polymorphisms), these variations affect on TNF-α gene expression. Polymorphism TNF-α gene in 
codon -308 G (guanine) has been reported in different autoimmune diseases as Rheumatoid arthritis. The 
genetic variation in codon -308 results in presence of two allelic features (G and A) in which G is defines as the 
common variant, and the presence of A(adenine) defines as less common.A allele displays increase TNF-α-308   
gene transcription expression to produce  6-7 folds as compared to G allele [8]. 
The study aim is evaluating association of TNF-α -308 G/A polymorphism with rheumatoid arthritis in Iraqi 
patients. 
2. Materials and Methods 
Rheumatoid arthritis Patients and controlstotal of 72 (42 Patients and 30 control) subjects visiting Abu-Graeeb 
hospitals and Al-Shaheed Saif Saad healthy center, Baghdad, Iraq were recruited (during 2016–2017) for this 
study. The diagnosis of RA consisted of 42 unrelated Iraqi rheumatoid arthritis patients [male = 15, female = 27, 
age range 30 to 72 years (mean age 55,67 ± 1,65 years)]. The control group consisted of 30 matched, unrelated 
healthy blood donors [male = 10, female = 20, age range 30 to 70 years (mean age 52,8 ± 2,10 years)] from the 
same Iraqi population. 
Genomic DNA extraction 
Genomic DNA was extracted from 200 µl of whole blood using the ReliaPrepᵀᴹBlood gDNAMiniprep System 
kit (promega). Concertation and purity ware detected using nanodrope. 
Cytokine genotyping 
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The TNF-α geneA and G alleles at positions -308 were genotype using the amplification refractory mutation 
system (ARMS-PCR) reaction. The PCR Primers sequences were used in present study are shown in table 
(1).The PCR conditions for ARMS Technique were in table (2).(Depending on [9] and [10] sources). 
Electrophoresis was dose by using 2 % agarose gel concentration for 1 hour, 75 Vol, stained with ethidium 
bromide. 
Table 1: The primers sequenceof TNFα (-308G/A) genotype 
 
Gene Locus 
 
Sequence of Generic primer (antisense)  Sequence of Sense primers  
TNFα (G-308A) 5′-TCT CGG TTT CTT CTC CAT CG-3′ 
G allele: 5′-ATA GGT TTT GAG GGG CAT GG-3′ 
A allele: 5′-AAT AGG TTT TGA GGG GCA TGA-3′ 
 
Table 2: The ARMS-PCR Technique using for TNFα (-308G/A) genotype. 
 
Subjects 
 
 
Cycles 
 
 
Heat 
 
 
S Time 
Pre-denaturation 1 94 5 min 
Denaturation 10 94 15 sec 
Annealing  65 50 sec 
Extension  72 40 sec 
Denaturation 25 94 20sec 
Annealing  59 50 sec 
Extension  72 50 sec 
Final extension 1 72 7 min 
 
3. Statistical analysis 
The differences in allele/genotype (TNF-α -308G/A) frequencies and significant between patients and controls 
were analyzed bythe Fisher’s exact test,Pvalues less than 0.05, were considered significant. The strength of the 
association of disease with respect to a particular allele/genotypeis expressed by odd ratio (OR), and Confidence 
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Intervals (CI) interpreted as relative risk (RR) following the Woolf’s method as out lined by Schallreuter and his 
colleagues [11]. It was calculated only for those alleles/genotypes which were increased or decreased in 
rheumatoid arthritis patients as compared to control group. The RR was calculated for all the subjects using the 
formula given below: 
RR = (a) × (d)/(b) × (c). 
a = number of patients with expression of allele orgenotype. 
b = number of patients without expression of alleleor genotype. 
c = number of controls with expression of allele orgenotype. 
d = number of controls without expression of allele or genotype. 
Etiologic Fraction (EF): 
The EF indicates the hypothetical genetic component ofthe disease. The values .0.0–0.99 is of significance. EF 
was calculated for positive association only where 
RR.1 using the following formula [12]. 
EF = (RR-1)f/RR, where f = a/a+c 
Preventive Fraction (PF): 
The PF indicates the hypothetical protective effectof one specific allele/genotype for the disease. PFwas 
calculated for negative association only whereRR, 1 using the following formula [12]. 
PF = (1-RR)f/RR (1-f) + f, where f = a/a+c 
Values,1.0 indicate the protective effect of the allele/genotype against the manifestation of disease. 
4. Results and discussion 
The results of present study show significant variation between alleles and genotype in patients and control. 
The genotype frequencies of TNFα -308G/A polymorphism in rheumatoid arthritis patients and control 
individuals ware presented in Table 1. The homozygous AAgenotype was more frequent and significantly in 
rheumatoid arthritis patient's 42.86% and odds ratio (OR) 4.88,p=0.009*, Compared to control 13.33%. The 
frequency of GG genotype was less in patients and control (11.90% and 3.33% sequentially), while 
heterozygous GA genotype was found in 45.24% of the rheumatoid arthritis patient's against 82.33% of controls 
(OR= O.17. P= 0.001*). The homozygous GG genotype and heterozygous GA genotype for TNFα -308 
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frequency in Iraqi data were similar to those reported in Saudi Rheumatoid [13], Egyptian [14], Tunisian [15] 
and Turkish [16] populations. In addition to the genotype frequency all for GG, GA and AA data were similar to 
Iraq populations [17]. Table 2 shows the alleles frequencies of TNFα -308G/A polymorphism in rheumatoid 
arthritis patients and control individuals.The frequency of alleles A and G was none significantly in patients and 
control p= 0.228 (OR= 1.55 and 0.64 sequentially), in addition the frequency A allele was higher in rheumatoid 
arthritis patient's as compared to the control. The alleles-308G/A polymorphism has been related to increased 
transcriptional activity of the TNF gene [18]. The search for a function for the -308G/A polymorphism the 
expression of TNF has produced controversial results [19]. However, the association of the TNF-α allele with 
susceptibility to play a central role in the development of a more severe form of rheumatoid arthritis [20].The 
prominent role played by tumor necrosis factor alpha  in inflammation and its relevance to both infectious and 
autoimmune diseases, has led to great interest in both the regulation of the TNF alpha gene, and the possibility 
that variants of the gene or deregulation of its production may be associated with rheumatoid arthritis [21]. have 
also recently reported an association of the -308G/A TNF polymorphism with the severity of the disease [22]. 
The firststudy of the _308 G/A Single nucleotide polymorphisms in relation to rheumatoid arthritis found no 
association between the frequency of the Single nucleotide polymorphisms and the incidence of rheumatoid 
arthritis [23]. Two subsequent Spanish studies alsofound no association between either _308G/A Single 
nucleotide polymorphisms and susceptibility to rheumatoid arthritis [24]. A large study of Japanese rheumatoid 
arthritis patients (n¼ for 545 patients) showed that while _308A allele was increased in rheumatoid arthritis 
patients [25]. had reported an increase in the _308A allele in RApatients, two recent studies from Taiwan30 and 
Sweden [26]. Reported an increased incidence of the _308G allele in rheumatoid arthritis patients, when 
compared to controls. In addition to studies of the incidence of rheumatoid arthritis, some researchers have 
examined the possible role of the allele and genotype variants in disease severity [27]. The study showed a 
association between the TNF-α gene in Loci -308 G/A polymorphism and rheumatoid arthritis. Show allele A 
and AA genotype associated links with rheumatoid arthritis. AA genotype frequency more than four times in 
TNF-α gene for Iraqi patients (table 3). This genotype is Etiologic Fraction in rheumatoid arthritis for Iraqi 
patients, While GG genotype Preventive Fraction in disease.  
Table 3: Genotype frequencies of TNF-α -308 G/A polymorphism in rheumatoid arthritis patients and controls 
 
CI 95% 
 
 
OR 
 
 
P-value 
(Two-tailed) 
 
Control(n=30) 
N(%) 
 
Rheumatoid 
arthritis(n=42) 
N(%) 
 
Genotype 
 
0.45 to 34.20 3.92 0.390 3.33 11.90 GG 
0.05 to 0.51 0.17 *0.001  83.33 45.24 GA 
1.47 to 16.16 4.88 *0.009  13.33 42.86 AA 
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Table 4: allelic frequencies of TNF-α -308 G/A polymorphism inrheumatoid arthritis patients and controls 
 
CI 95% 
 
 
OR 
 
P-value 
(Two-tailed) 
 
Control(n=30) 
N(%) 
 
Rheumatoid 
arthritis(n=42) 
N(%) 
 
Genotype 
 
0.79 to 3.04 1.55 0.228  55.00 65.48 A 
0.33 to 1.26 0.64 0.228 45.00 34.52 G 
 
 
Figure 1: Electrophoresis for TNF-α -308 G/A genotype in same in rheumatoid arthritis patients, lane M DNA 
marker (100 to 1500 bp), lane 1,5,9,10,11 AA genotype, lane 2,3,4,7,12 GA  genotype, lane 6,8 GG genotype. 
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